Danaher - Latest News and Investment Deals
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
DHR
Danaher is a global leader in life sciences and diagnostics, dedicated to accelerating the power of science and technology to improve human health. The company operates through biotechnology, diagnostics, and life sciences businesses, developing tools, technologies, and services that advance therapies, research, and patient care. Danaher emphasizes a continuous improvement culture via the Danaher Business System to drive collaboration, acquisitions, and partnerships across its worldwide operations. Headquartered in Washington, D.C., USA, the group serves customers across healthcare, research institutions, and industrial markets.
HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs
Lawhive Closes $60M Series B for Consumer Legal AI
IDBS Celebrates Customer Successes and Product Innovations in 2025
Chapters Group: German Conglomerate Aiming to Be the Next Berkshire Hathaway
Lee Ainslie: Concentrating Capital in AI Leaders While Pruning Legacy Positions
Lawhive Raises $60M in Series B Funding
Automata Secures $45M Series C to Build the Operating System for AI-Ready Labs
Lee Ainslie Portfolio Analysis: Key Positions, AI Bets & Maverick Capital Strategy
Siemens Healthineers Appoints New Chief Technology Officer
Sources: US Healthcare Manufacturer Danaher Is Nearing a Deal to Buy Medtech Company Masimo for ~$10B; Masimo Is in an IP Dispute with Apple over Apple Watch (Financial Times)
